BioTuesdays

Tag - myocardial infraction

Medicure to leverage sales model to new products

By Len Zehr Medicure (TSXV:MPH) intends to leverage its unique sales and marketing model, which has fueled the growth of its Aggrastat IV platelet inhibitor, as it brings new generic products into its cardiovascular...